CRTh2 receptor antagonists (Novartis)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug NameCRTh2 receptor antagonists (Novartis)
Drug Alias NameDP2 receptor antagonists (Novartis)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstaglandin D2 receptor 2 antagonistsProstaglandin-H2 D-isomerase inhibitors
TargetsProstaglandin-H2 D-isomeraseProstaglandin D2 receptor 2
Therapy Area/IndicationsInflammationHypersensitivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Ag
Active IndicationsN/A
Inactive IndicationsInflammationHypersensitivity

Other Information

ATC CodeN/A
Related LinksN/A